2 active not recruiting, 1 completed, 1 terminated. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Active not recruiting 1 |
Follow Biocept, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide CNSide - Leptomeningeal Metastasis, Leptomeningeal Disease | Terminated | Biocept, Inc. | 40 | 2022-09-07 | 2023-10-16 | |
| Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins Treatment recommendation - Metastatic Breast Cancer | Not applicable | Active not recruiting | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 200 | 2018-01-26 | 2026-06-08 |
| Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer OncoCEE - Breast Cancer, Leptomeningeal Metastasis | Completed | Columbia University | 14 | 2017-02-06 | 2024-06-06 | |
| Molecular Studies and Clinical Correlations in Human Prostatic Disease Prostate Cancer | Active not recruiting | Memorial Sloan Kettering Cancer Center | 5290 | 1990-04-01 | 2026-03-09 |
Breast Neoplasms (3) · Meningeal Carcinomatosis (2) · Carcinoma, Non-Small-Cell Lung (1) · Meningeal Neoplasms (1) · Prostatic Neoplasms (1)
United States (4)
Jenna Canzoniero, MD (1) · Priya Kumthekar, MD (1) · Susan Slovin, MD (1) · Vered Stearns, M.D. (1)
R03CA208547 (1)